Needleless Injectors Market Forecast (2024-2031)
The Needleless Injectors Market is expected to register a CAGR of 18.2% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Needleless Injectors Market by Type (Liquid-Based, Projectile/Depot-Based, and Powder-Based); Product (Fillable, and Prefilled); Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors); Application (Vaccine Delivery, Insulin Delivery, Pain Management, and Others); End Use (Hospitals and Clinics, Home Care Settings, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Needleless Injectors Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Needleless Injectors Market Segmentation
by Type- Liquid-Based
- Projectile/Depot-Based
- Powder-Based
- Fillable
- Prefilled
- Subcutaneous Injectors
- Intramuscular Injectors
- Intradermal Injectors
- Vaccine Delivery
- Insulin Delivery
- Pain Management
- Others
- Vaccine Delivery
- Insulin Delivery
- Pain Management
- Others
Strategic Insights
Needleless Injectors Market Growth Drivers- Increasing Demand for Pain Free Drug Delivery:There is a growing requirement for pain-free drug delivery systems, particularly among patients who have needle phobia. Needle-free injectors provide a non-invasive and painless alternative, making them increasingly popular in both healthcare settings and home care environments
- Rising Prevalence of Chronic Diseases: The need for efficient medication delivery techniques has increased as a result of the rising prevalence of chronic illnesses like diabetes, cancer, and autoimmune disorders. Because they make the process of administering medication easier, needle-free injectors are especially beneficial for patients who need to take it frequently.
- Government Initiatives and Healthcare Expenditure:The adoption of needle-free injectors is being aided by increased government measures to improve healthcare spending and infrastructure. These gadgets are more likely to be included into medical procedures in nations with developed healthcare systems.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Technological Developments:Their appeal is being increased by advancements in needle-free injector technology, such as increased accuracy and user-friendliness. In order to produce more effective and user-friendly products, manufacturers are spending money on research and development, which should propel market expansion even further.
- Growth in Vaccine Administration: Interest in needle-free injectors for vaccine distribution increased as a result of the COVID-19 pandemic, which brought attention to the need for effective immunization techniques. As public health initiatives concentrate on mass immunization campaigns, this tendency is anticipated to continue.
- Self-Administration Trends:Patients are increasingly choosing to administer their own prescriptions, particularly in home care settings. By removing the need for conventional needles, needle-free injectors enable patients to independently control their medications, contributing to this trend.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Microfluidics and Nanotechnology: Thanks to developments in microfluidics, medicine distribution can be precisely controlled, resulting in customized dosages and less pharmaceutical waste. Drug formulation is improved via nanotechnology, which increases the stability and bioavailability of medications when administered using needle-free methods.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Smart Features and Connectivity: Smart technologies are being incorporated into newer needle-free injectors, enabling them to link to mobile devices for data processing and monitoring. With this feature, medical professionals can monitor drug compliance and modify treatment regimens in real time. Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Laser-Powered Injectors:Injectors without needles are incorporating laser technology, which enables accurate skin penetration without endangering the drug or underlying tissues. This technique lowers the possibility of problems related to conventional injections while improving patient comfort.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Needleless Injectors Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Needleless Injectors Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
In Europe, the UK held the second largest share in 2023.
Asia pacific region is expected to witness the highest growth during the forecast period
Microfluidics and Nanotechnology
North America held the largest share in 2023 and is expected to retain its dominance during the forecast period
Increasing Demand for Pain Free Drug Delivery
The Needleless Injectors Market is estimated to witness a CAGR of 18.2% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Needleless Injectors Market - By Type
1.3.2 Needleless Injectors Market - By Product
1.3.3 Needleless Injectors Market - By Site of Delivery
1.3.4 Needleless Injectors Market - By Application
1.3.5 Needleless Injectors Market - By End Use
1.3.6 Needleless Injectors Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEEDLELESS INJECTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEEDLELESS INJECTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEEDLELESS INJECTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEEDLELESS INJECTORS - GLOBAL MARKET OVERVIEW
6.2. NEEDLELESS INJECTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NEEDLELESS INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LIQUID-BASED
7.3.1. Overview
7.3.2. Liquid-Based Market Forecast and Analysis
7.4. PROJECTILE/DEPOT-BASED
7.4.1. Overview
7.4.2. Projectile/Depot-Based Market Forecast and Analysis
7.5. POWDER-BASED
7.5.1. Overview
7.5.2. Powder-Based Market Forecast and Analysis
8. NEEDLELESS INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. FILLABLE
8.3.1. Overview
8.3.2. Fillable Market Forecast and Analysis
8.4. PREFILLED
8.4.1. Overview
8.4.2. Prefilled Market Forecast and Analysis
9. NEEDLELESS INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - SITE OF DELIVERY
9.1. OVERVIEW
9.2. SITE OF DELIVERY MARKET FORECASTS AND ANALYSIS
9.3. SUBCUTANEOUS INJECTORS
9.3.1. Overview
9.3.2. Subcutaneous Injectors Market Forecast and Analysis
9.4. INTRAMUSCULAR INJECTORS
9.4.1. Overview
9.4.2. Intramuscular Injectors Market Forecast and Analysis
9.5. INTRADERMAL INJECTORS
9.5.1. Overview
9.5.2. Intradermal Injectors Market Forecast and Analysis
10. NEEDLELESS INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. VACCINE DELIVERY
10.3.1. Overview
10.3.2. Vaccine Delivery Market Forecast and Analysis
10.4. INSULIN DELIVERY
10.4.1. Overview
10.4.2. Insulin Delivery Market Forecast and Analysis
10.5. PAIN MANAGEMENT
10.5.1. Overview
10.5.2. Pain Management Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. NEEDLELESS INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
11.1. OVERVIEW
11.2. END USE MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS AND CLINICS
11.3.1. Overview
11.3.2. Hospitals and Clinics Market Forecast and Analysis
11.4. HOME CARE SETTINGS
11.4.1. Overview
11.4.2. Home Care Settings Market Forecast and Analysis
11.5. RESEARCH LABORATORIES
11.5.1. Overview
11.5.2. Research Laboratories Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis
12. NEEDLELESS INJECTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Needleless Injectors Market Overview
12.1.2 North America Needleless Injectors Market Forecasts and Analysis
12.1.3 North America Needleless Injectors Market Forecasts and Analysis - By Type
12.1.4 North America Needleless Injectors Market Forecasts and Analysis - By Product
12.1.5 North America Needleless Injectors Market Forecasts and Analysis - By Site of Delivery
12.1.6 North America Needleless Injectors Market Forecasts and Analysis - By Application
12.1.7 North America Needleless Injectors Market Forecasts and Analysis - By End Use
12.1.8 North America Needleless Injectors Market Forecasts and Analysis - By Countries
12.1.8.1 United States Needleless Injectors Market
12.1.8.1.1 United States Needleless Injectors Market by Type
12.1.8.1.2 United States Needleless Injectors Market by Product
12.1.8.1.3 United States Needleless Injectors Market by Site of Delivery
12.1.8.1.4 United States Needleless Injectors Market by Application
12.1.8.1.5 United States Needleless Injectors Market by End Use
12.1.8.2 Canada Needleless Injectors Market
12.1.8.2.1 Canada Needleless Injectors Market by Type
12.1.8.2.2 Canada Needleless Injectors Market by Product
12.1.8.2.3 Canada Needleless Injectors Market by Site of Delivery
12.1.8.2.4 Canada Needleless Injectors Market by Application
12.1.8.2.5 Canada Needleless Injectors Market by End Use
12.1.8.3 Mexico Needleless Injectors Market
12.1.8.3.1 Mexico Needleless Injectors Market by Type
12.1.8.3.2 Mexico Needleless Injectors Market by Product
12.1.8.3.3 Mexico Needleless Injectors Market by Site of Delivery
12.1.8.3.4 Mexico Needleless Injectors Market by Application
12.1.8.3.5 Mexico Needleless Injectors Market by End Use
12.2. EUROPE
12.2.1 Europe Needleless Injectors Market Overview
12.2.2 Europe Needleless Injectors Market Forecasts and Analysis
12.2.3 Europe Needleless Injectors Market Forecasts and Analysis - By Type
12.2.4 Europe Needleless Injectors Market Forecasts and Analysis - By Product
12.2.5 Europe Needleless Injectors Market Forecasts and Analysis - By Site of Delivery
12.2.6 Europe Needleless Injectors Market Forecasts and Analysis - By Application
12.2.7 Europe Needleless Injectors Market Forecasts and Analysis - By End Use
12.2.8 Europe Needleless Injectors Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Needleless Injectors Market
12.2.8.1.1 Germany Needleless Injectors Market by Type
12.2.8.1.2 Germany Needleless Injectors Market by Product
12.2.8.1.3 Germany Needleless Injectors Market by Site of Delivery
12.2.8.1.4 Germany Needleless Injectors Market by Application
12.2.8.1.5 Germany Needleless Injectors Market by End Use
12.2.8.2 France Needleless Injectors Market
12.2.8.2.1 France Needleless Injectors Market by Type
12.2.8.2.2 France Needleless Injectors Market by Product
12.2.8.2.3 France Needleless Injectors Market by Site of Delivery
12.2.8.2.4 France Needleless Injectors Market by Application
12.2.8.2.5 France Needleless Injectors Market by End Use
12.2.8.3 Italy Needleless Injectors Market
12.2.8.3.1 Italy Needleless Injectors Market by Type
12.2.8.3.2 Italy Needleless Injectors Market by Product
12.2.8.3.3 Italy Needleless Injectors Market by Site of Delivery
12.2.8.3.4 Italy Needleless Injectors Market by Application
12.2.8.3.5 Italy Needleless Injectors Market by End Use
12.2.8.4 Spain Needleless Injectors Market
12.2.8.4.1 Spain Needleless Injectors Market by Type
12.2.8.4.2 Spain Needleless Injectors Market by Product
12.2.8.4.3 Spain Needleless Injectors Market by Site of Delivery
12.2.8.4.4 Spain Needleless Injectors Market by Application
12.2.8.4.5 Spain Needleless Injectors Market by End Use
12.2.8.5 United Kingdom Needleless Injectors Market
12.2.8.5.1 United Kingdom Needleless Injectors Market by Type
12.2.8.5.2 United Kingdom Needleless Injectors Market by Product
12.2.8.5.3 United Kingdom Needleless Injectors Market by Site of Delivery
12.2.8.5.4 United Kingdom Needleless Injectors Market by Application
12.2.8.5.5 United Kingdom Needleless Injectors Market by End Use
12.2.8.6 Rest of Europe Needleless Injectors Market
12.2.8.6.1 Rest of Europe Needleless Injectors Market by Type
12.2.8.6.2 Rest of Europe Needleless Injectors Market by Product
12.2.8.6.3 Rest of Europe Needleless Injectors Market by Site of Delivery
12.2.8.6.4 Rest of Europe Needleless Injectors Market by Application
12.2.8.6.5 Rest of Europe Needleless Injectors Market by End Use
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Needleless Injectors Market Overview
12.3.2 Asia-Pacific Needleless Injectors Market Forecasts and Analysis
12.3.3 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By Product
12.3.5 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By Site of Delivery
12.3.6 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By Application
12.3.7 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By End Use
12.3.8 Asia-Pacific Needleless Injectors Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Needleless Injectors Market
12.3.8.1.1 Australia Needleless Injectors Market by Type
12.3.8.1.2 Australia Needleless Injectors Market by Product
12.3.8.1.3 Australia Needleless Injectors Market by Site of Delivery
12.3.8.1.4 Australia Needleless Injectors Market by Application
12.3.8.1.5 Australia Needleless Injectors Market by End Use
12.3.8.2 China Needleless Injectors Market
12.3.8.2.1 China Needleless Injectors Market by Type
12.3.8.2.2 China Needleless Injectors Market by Product
12.3.8.2.3 China Needleless Injectors Market by Site of Delivery
12.3.8.2.4 China Needleless Injectors Market by Application
12.3.8.2.5 China Needleless Injectors Market by End Use
12.3.8.3 India Needleless Injectors Market
12.3.8.3.1 India Needleless Injectors Market by Type
12.3.8.3.2 India Needleless Injectors Market by Product
12.3.8.3.3 India Needleless Injectors Market by Site of Delivery
12.3.8.3.4 India Needleless Injectors Market by Application
12.3.8.3.5 India Needleless Injectors Market by End Use
12.3.8.4 Japan Needleless Injectors Market
12.3.8.4.1 Japan Needleless Injectors Market by Type
12.3.8.4.2 Japan Needleless Injectors Market by Product
12.3.8.4.3 Japan Needleless Injectors Market by Site of Delivery
12.3.8.4.4 Japan Needleless Injectors Market by Application
12.3.8.4.5 Japan Needleless Injectors Market by End Use
12.3.8.5 South Korea Needleless Injectors Market
12.3.8.5.1 South Korea Needleless Injectors Market by Type
12.3.8.5.2 South Korea Needleless Injectors Market by Product
12.3.8.5.3 South Korea Needleless Injectors Market by Site of Delivery
12.3.8.5.4 South Korea Needleless Injectors Market by Application
12.3.8.5.5 South Korea Needleless Injectors Market by End Use
12.3.8.6 Indonesia Needleless Injectors Market
12.3.8.6.1 Indonesia Needleless Injectors Market by Type
12.3.8.6.2 Indonesia Needleless Injectors Market by Product
12.3.8.6.3 Indonesia Needleless Injectors Market by Site of Delivery
12.3.8.6.4 Indonesia Needleless Injectors Market by Application
12.3.8.6.5 Indonesia Needleless Injectors Market by End Use
12.3.8.7 Rest of Asia-Pacific Needleless Injectors Market
12.3.8.7.1 Rest of Asia-Pacific Needleless Injectors Market by Type
12.3.8.7.2 Rest of Asia-Pacific Needleless Injectors Market by Product
12.3.8.7.3 Rest of Asia-Pacific Needleless Injectors Market by Site of Delivery
12.3.8.7.4 Rest of Asia-Pacific Needleless Injectors Market by Application
12.3.8.7.5 Rest of Asia-Pacific Needleless Injectors Market by End Use
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Needleless Injectors Market Overview
12.4.2 Middle East and Africa Needleless Injectors Market Forecasts and Analysis
12.4.3 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By Product
12.4.5 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By Site of Delivery
12.4.6 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By Application
12.4.7 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By End Use
12.4.8 Middle East and Africa Needleless Injectors Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Needleless Injectors Market
12.4.8.1.1 South Africa Needleless Injectors Market by Type
12.4.8.1.2 South Africa Needleless Injectors Market by Product
12.4.8.1.3 South Africa Needleless Injectors Market by Site of Delivery
12.4.8.1.4 South Africa Needleless Injectors Market by Application
12.4.8.1.5 South Africa Needleless Injectors Market by End Use
12.4.8.2 Saudi Arabia Needleless Injectors Market
12.4.8.2.1 Saudi Arabia Needleless Injectors Market by Type
12.4.8.2.2 Saudi Arabia Needleless Injectors Market by Product
12.4.8.2.3 Saudi Arabia Needleless Injectors Market by Site of Delivery
12.4.8.2.4 Saudi Arabia Needleless Injectors Market by Application
12.4.8.2.5 Saudi Arabia Needleless Injectors Market by End Use
12.4.8.3 U.A.E Needleless Injectors Market
12.4.8.3.1 U.A.E Needleless Injectors Market by Type
12.4.8.3.2 U.A.E Needleless Injectors Market by Product
12.4.8.3.3 U.A.E Needleless Injectors Market by Site of Delivery
12.4.8.3.4 U.A.E Needleless Injectors Market by Application
12.4.8.3.5 U.A.E Needleless Injectors Market by End Use
12.4.8.4 Rest of Middle East and Africa Needleless Injectors Market
12.4.8.4.1 Rest of Middle East and Africa Needleless Injectors Market by Type
12.4.8.4.2 Rest of Middle East and Africa Needleless Injectors Market by Product
12.4.8.4.3 Rest of Middle East and Africa Needleless Injectors Market by Site of Delivery
12.4.8.4.4 Rest of Middle East and Africa Needleless Injectors Market by Application
12.4.8.4.5 Rest of Middle East and Africa Needleless Injectors Market by End Use
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Needleless Injectors Market Overview
12.5.2 South and Central America Needleless Injectors Market Forecasts and Analysis
12.5.3 South and Central America Needleless Injectors Market Forecasts and Analysis - By Type
12.5.4 South and Central America Needleless Injectors Market Forecasts and Analysis - By Product
12.5.5 South and Central America Needleless Injectors Market Forecasts and Analysis - By Site of Delivery
12.5.6 South and Central America Needleless Injectors Market Forecasts and Analysis - By Application
12.5.7 South and Central America Needleless Injectors Market Forecasts and Analysis - By End Use
12.5.8 South and Central America Needleless Injectors Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Needleless Injectors Market
12.5.8.1.1 Brazil Needleless Injectors Market by Type
12.5.8.1.2 Brazil Needleless Injectors Market by Product
12.5.8.1.3 Brazil Needleless Injectors Market by Site of Delivery
12.5.8.1.4 Brazil Needleless Injectors Market by Application
12.5.8.1.5 Brazil Needleless Injectors Market by End Use
12.5.8.2 Argentina Needleless Injectors Market
12.5.8.2.1 Argentina Needleless Injectors Market by Type
12.5.8.2.2 Argentina Needleless Injectors Market by Product
12.5.8.2.3 Argentina Needleless Injectors Market by Site of Delivery
12.5.8.2.4 Argentina Needleless Injectors Market by Application
12.5.8.2.5 Argentina Needleless Injectors Market by End Use
12.5.8.3 Rest of South and Central America Needleless Injectors Market
12.5.8.3.1 Rest of South and Central America Needleless Injectors Market by Type
12.5.8.3.2 Rest of South and Central America Needleless Injectors Market by Product
12.5.8.3.3 Rest of South and Central America Needleless Injectors Market by Site of Delivery
12.5.8.3.4 Rest of South and Central America Needleless Injectors Market by Application
12.5.8.3.5 Rest of South and Central America Needleless Injectors Market by End Use
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEEDLELESS INJECTORS MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Middle East and Africa
13.5 South and Central America
1. Antares Pharma, Inc.
2. PharmaJet
3. PenJet Corporation
4. Medical International Technology, Inc.
5. INJEX Pharma AG
6. Crossject needle-free injection systems
7. National Medical Products Inc.
8. Valeritas, Inc.
9. European Pharma Group
10. Endo International plc
11. Bioject Medical Technologies Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.